Galderma Buys Back Shares Worth CHF 233 Million in the Context of Accelerated Bookbuild Offering
The repurchase, which is expected to settle on June 2, is being financed by Galderma's existing liquidity on hand and will not affect the company's ability to deliver on its strategic and financing priorities.
The shares will be held in treasury for future use in connection with Galderma's employee participation plans, business development opportunities and/or treasury management.
'The repurchase of shares announced today is a testament to the confidence of the Executive Committee and the Board of Directors in the performance fundamentals and the attractive shareholder value creation outlook of Galderma. The participation in the offering reflects our continued focus on disciplined capital allocation, commitment to attractive shareholder returns and our confidence in Galderma's strong cash generation and investment grade balance sheet.'
FLEMMING ØRNSKOV, M.D., MPH
CHIEF EXECUTIVE OFFICER
GALDERMA
Expand
Following the closing of the ABO, the free float in Galderma's shares is expected to increase from 41.8% to 49.8%.
About Galderma
Galderma (SIX: GALD) is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body's largest organ – the skin – meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we are in shapes our lives, we are advancing dermatology for every skin story. For more information: www.galderma.com.
Forward-looking statements
Certain statements in this announcement are forward-looking statements. Forward-looking statements are statements that are not historical facts and may be identified by words such as "plans", "targets", "aims", " believes", "expects", "anticipates", "intends", "estimates", "will", "may", "continues", "should" and similar expressions. These forward-looking statements reflect, at the time, Galderma's beliefs, intentions and current targets/ aims concerning, among other things, Galderma's results of operations, financial condition, industry, liquidity, prospects, growth and strategies and are subject to change. The estimated financial information is based on management's current expectations and is subject to change. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial consequences of the plans and events described herein. Actual results may differ from those set forth in the forward-looking statements as a result of various factors (including, but not limited to, future global economic conditions, changed market conditions, intense competition in the markets in which Galderma operates, costs of compliance with applicable laws, regulations and standards, diverse political, legal, economic and other conditions affecting Galderma's markets, and other factors beyond the control of Galderma). Neither Galderma nor any of their respective shareholders (as applicable), directors, officers, employees, advisors, or any other person is under any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You should not place undue reliance on forward-looking statements, which speak of the date of this announcement. Statements contained in this announcement regarding past trends or events should not be taken as a representation that such trends or events will continue in the future. Some of the information presented herein is based on statements by third parties, and no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, reasonableness, accuracy, completeness or correctness of this information or any other information or opinions contained herein, for any purpose whatsoever. Except as required by applicable law, Galderma has no intention or obligation to update, keep updated or revise this announcement or any parts thereof.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
9 minutes ago
- Business Wire
Accord Announces Amendment to its Banking Facility
TORONTO--(BUSINESS WIRE)--Accord Financial Corp. (TSX – ACD) today announced it has amended its senior secured revolving credit facility (the 'Credit Facility'), extending the maturity date to December 15, 2025. This amendment follows two recent short-term extensions: the first announced on July 25, 2025, and the second on August 8, 2025, which extended the maturity date to August 15, 2025. Under the new terms, the total commitment will be reduced from $260 million to $200 million. The amendment also incorporates milestones tied to potential asset sales (with net proceeds to be used to repay bank indebtedness), increases the interest rate on drawn amounts by 1.00%, and updates certain financial covenants. 'While the amendment includes higher pricing and a reduced commitment, the extension provides time for the Company to continue to actively pursue a broad range of strategic initiatives to address the Company's maturing debt obligations (totalling $217.6 million as at June 30, 2025 and coming due by January 31, 2026) and maximize shareholder value,' said Mr. Hitzig. 'These include potential divestitures of portfolio assets or business units, as well as other financing alternatives. The Company continues to work closely with its financial advisors, but there is no assurance that these initiatives will yield a successful result. While we focus on these initiatives, profitable operating performance and growth will continue to be a challenge.' The Company does not plan to provide further updates on its strategic initiatives unless material developments emerge. A Material Change Report and the amended Credit Facility agreement will be filed on SEDAR+ at About Accord Financial Corp. Accord Financial is one of North America's most dynamic commercial finance companies providing fast, versatile financing solutions including asset-based lending, factoring, inventory finance, equipment finance (in Canada), trade finance and film/media finance. By leveraging our unique combination of deep experience and independent thinking, we craft winning financial solutions for small and medium-sized businesses, simply delivered, so our clients can thrive. For further information please visit or contact: Forward-Looking Statements This news release contains certain "forward-looking statements" and certain "forward-looking information" as defined under applicable Canadian securities laws. Forward-looking statements can generally be identified by the use of forward-looking terminology such as "may", "will", "expect", "intend", "estimate", "anticipate", "believe", "continue", "plans" or similar terminology. Forward-looking statements in this news release include, but are not limited to, statements, management's beliefs, expectations or intentions regarding the financial position of the Company and the ability of the Company to repay or refinance its outstanding debt obligations. Forward-looking statements are based on forecasts of future results, estimates of amounts not yet determinable and assumptions that while believed by management to be reasonable, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Forward-looking statements are subject to various risks and uncertainties including the Company's overall liquidity and capital resource position and its ability to repay its debt obligations when due and those risks identified in the Accord's periodic filings with Canadian securities regulators. If any or all of the Company's outstanding debt obligations are not renewed or replaced upon expiration of their terms, and if the Company is unsuccessful in its ability to generate additional capital from sales of portfolio assets and/or business units and additional alternative financing arrangements to repay same on terms acceptable to the Company, or at all, the Company may not be able to continue to finance its operations and operate as a going concern. See Accord's most recent annual information form and most recent management's discussion and analysis of results of operations and financial condition for a detailed discussion of the risk factors affecting Accord. Such forward-looking information represents management's best judgment based on information currently available. No forward-looking statement can be guaranteed and actual future results may vary materially. Accordingly, readers are advised not to place undue reliance on forward-looking statements or information.
Business Wire
an hour ago
- Business Wire
LifeX Term Income ETFs Announce the Closure and Liquidation of Two Exchange-Traded Funds
NEW YORK--(BUSINESS WIRE)--LifeX Term Income ETFs ('LifeX') has announced that it will close and liquidate two exchange-traded funds to simplify its fund lineup. LifeX will be liquidating the LifeX 2040 Term Income ETF and LifeX 2045 Term Income ETF (together, the 'Liquidating ETFs') (such transactions, the 'Liquidations'). The Liquidations are expected to take place on or about August 22, 2025 (the 'Liquidation Date'). August 20, 2025 is expected to be the last full day of trading for the Liquidating ETFs' shares. The Liquidating ETFs expect to operate pursuant to their stated investment strategies through the Liquidation Date. While the investment objective of each Liquidating ETF is to provide monthly distributions through the year in such Liquidating ETF's name, the Liquidating ETFs will instead seek to liquidate and distribute their remaining assets to shareholders promptly following the Liquidation Date. In each case, the liquidation proceeds are expected to be distributed promptly following the Liquidation Date in full redemption of each shareholder's shares of the Liquidating ETFs. For additional information about the liquidations, shareholders of the Liquidating ETFs may call 855-609-3680. About LifeX Term Income ETFs LifeX Term Income ETFs are designed to provide reliable monthly distributions consisting of income and principal through the end of a calendar year specified in the ETF's prospectus. To learn more, please visit Risk Disclosures Investing involves risk. Principal loss is possible. Investors should consider the investment objectives, risks, charges, and expenses carefully before investing. For a prospectus with this and other information about the fund, please visit or call 855-609-3680. Please read the prospectus carefully before investing. Distributed by Foreside Financial Services, LLC.
Associated Press
an hour ago
- Associated Press
LifeX Term Income ETFs Announce the Closure and Liquidation of Two Exchange-Traded Funds
NEW YORK--(BUSINESS WIRE)--Aug 15, 2025-- LifeX Term Income ETFs ('LifeX') has announced that it will close and liquidate two exchange-traded funds to simplify its fund lineup. LifeX will be liquidating the LifeX 2040 Term Income ETF and LifeX 2045 Term Income ETF (together, the 'Liquidating ETFs') (such transactions, the 'Liquidations'). The Liquidations are expected to take place on or about August 22, 2025 (the 'Liquidation Date'). August 20, 2025 is expected to be the last full day of trading for the Liquidating ETFs' shares. The Liquidating ETFs expect to operate pursuant to their stated investment strategies through the Liquidation Date. While the investment objective of each Liquidating ETF is to provide monthly distributions through the year in such Liquidating ETF's name, the Liquidating ETFs will instead seek to liquidate and distribute their remaining assets to shareholders promptly following the Liquidation Date. In each case, the liquidation proceeds are expected to be distributed promptly following the Liquidation Date in full redemption of each shareholder's shares of the Liquidating ETFs. For additional information about the liquidations, shareholders of the Liquidating ETFs may call 855-609-3680. Investors should consider the investment objectives, risks, charges, and expenses carefully before investing. For a prospectus with this and other information about the fund, please visit or call 855-609-3680. Please read the prospectus carefully before investing. Distributed by Foreside Financial Services, LLC. View source version on CONTACT: Media Contact Marc Feuerstein [email protected] KEYWORD: UNITED STATES NORTH AMERICA NEW YORK INDUSTRY KEYWORD: ASSET MANAGEMENT PROFESSIONAL SERVICES FINANCE SOURCE: Stone Ridge Holdings Group Copyright Business Wire 2025. PUB: 08/15/2025 05:00 PM/DISC: 08/15/2025 05:00 PM
